Sayoko E. Moroi, M.D., Ph.D.
Publications

• Kamyar R, Weizer JS, Heitor de Paula F, et al. Glaucoma associated with Boston type I
  keratoprosthesis. Cornea [in press]
• Zhang L, Yang S, Johnson MW, Richards JE, Moroi, SE . Combined cilioretinal artery and
  central vein occlusions in juvenile glaucoma. Arch Ophthalmol 2011;129:1231-1234
• Weizer JS, Goyal A, Ple-Plakon P, Trzcinka A, Strong BD, Bruno CA , Junn J, Tseng I, Niziol LM, Musch DC, Moroi SE. Bleb morphology characteristics and effect on positional intraocular pressure variation. Ophthalmic Surg Lasers Imaging 2010;41:532-537.
• Moroi SE. Eyelash preservation during chemotherapy and topical prostaglandin therapy. Arch Intern Med 2010;170(14):1269-1270.
• Allingham, R., Damji, K. Freedman, S., Moroi, S.E., and Rhee, D. Shields' textbook of glaucoma, 6th ed. Philadelphia: Lippincott, Williams & Wilkins; 2010.
• John DA, Stein JD, Moroi SE. Intraocular foreign bodies. Eyenet, September 2009.
• Elner VM, Newman-Casey PA, Patil AJ, Flint A, Biswas J, Moroi SE, Pushparaj V, Edward DP. Aberrant wound-healing response in mitomycin C-treated leaking blebs: a histopathologic study. Arch Ophthalmol 2009;127:1036-1042.
• Roberts DK, Lukic AS, Yang Y, Moroi SE, Wilensky JT, Wernick MN. Novel observations and potential applications using digital infrared iris imaging. Ophthalmic Surg Lasers Imaging 2009;40:207-216.
• Roberts DK, Ayyagari R, Moroi SE. Possible association between long anterior lens zonules and plateau iris configuration. J Glaucoma 2008;17:393-396.
• Moroi SE, Heckenlively JR. Progress toward personalized medicine for age-related macular degeneration. Ophthalmology 2008;115:925-926.
• Trzcinka A, Soans FP, Archer SM, Moroi SE. Late-onset Haemophilus Influenzae Endophthalmitis in an Immunized Child after Baerveldt Implant. J Aapos 2008.
• Rozsa FW, Scott K, Pawar H, Moroi S, Richards JE. Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels. Arch Ophthalmol 2008;126:86-93.
• Johnson CS, Mian SI, Moroi S, Epstein D, Izatt J, Afshari NA. Role of corneal elasticity in damping of intraocular pressure. Invest Ophthalmol Vis Sci 2007;48:2540-2544.
• Bruno CA, Fisher GJ, Moroi SE. Is 'scarless wound healing' applicable to glaucoma surgery? Expert Rev Ophthalmol 2007;2:79-90.
• Ayala-Lugo RM, Pawar H, Reed DM, Lichter PR, Moroi SE, Page M, Eadie J, Azocar V, Maul E, Ntim-Amponsah C, Bromley W, Obeng-Nyarkoh E, Johnson AT, Kijek TG, Downs CA, Johnson JM, Perez-Grossmann RA, Guevara-Fujita ML, Fujita R, Wallace MR, Richards JE. Variation in optineurin (OPTN) allele frequencies between and within populations. Mol Vis 2007;13:151-163.
• McLaren N, Reed DM, Musch DC, Downs CA, Higashi ME, Santiago C, Radenbaugh PA, Allingham RR, Richards JE, Moroi SE. Evaluation of the beta2-adrenergic receptor gene as a candidate glaucoma gene in 2 ancestral populations. Arch Ophthalmol 2007;125:105-111.
• Mandal MN, Vasireddy V, Reddy GB, Wang X, Moroi SE, Pattnaik BR, Hughes BA, Heckenlively JR, Hitchcock PF, Jablonski MM, Ayyagari R. CTRP5 is a membrane-associated and secretory protein in the RPE and ciliary body and the S163R mutation of CTRP5 impairs its secretion. Invest Ophthalmol Vis Sci 2006;47:5505-5513.
• Radenbaugh PA, Goyal A, McLaren NC, et al. Concordance of aqueous humor flow in the morning and at night in normal humans. Invest Ophthalmol Vis Sci 2006;47:4860-4864.
• Eisengart J, Goings L, Prusak R, Hackel R, Archer S, Moroi SE.  Surgical management of unilateral glaucoma associated with poland sequence. Arch Ophthalmol 2006;124:1206-1207.
• Woodroffe A, Krafchak CM, Fuse N, et al. Ordered subset analysis supports a glaucoma locus at GLC1I on chromosome 15 in families with earlier adult age at diagnosis. Exp Eye Res 2006;82:1068-1074.
• Bruno CA, Eisengart JA, Radenbaugh PA, Moroi SE. Subconjunctival placement of human amniotic membrane during high risk glaucoma filtration surgery. Ophthalmic Surg Lasers Imaging 2006;37:190-197.
• Rozsa FW, Reed DM, Scott KM, et al. Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol Vis 2006;12:125-141.
• West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol 2006;141:157-166.
• Krafchak CM, Pawar H, Moroi SE, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am J Hum Genet 2005 Nov;77(5):694-708.
• Ayyagari R, Mandal MNA, Karoukis AJ, et al.  Long anterior lens zonules and late onset retinal degeneration are caused by a CTRP5 gene mutation.  Invest Ophthalmol Vis Sci 2005;46:3363-3371.
• Eibschitz-Tsimhoni M, Schertzer RM, Musch DC, Moroi SE. Incidence and management of encapsulated cysts following Ahmed glaucoma valve insertion. J Glaucoma 2005;14:276-9.
• Zareparsi S, Buraczynska M, Branham KE, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005;14:1449-1455.
• Allingham R, Damji K, Freedman S, Moroi SE, Shafranov G. Shields' Textbook of Glaucoma, 5th ed. Philadelphia:Lippincott Williams & Wilkins; 2005.
• Halkiadakis I, Lim P, Moroi SE. Surgical results of bleb revision with scleral patch graft for late-onset bleb complications. Ophthalmic Surg Lasers Imaging 2005;36:14-23.
• Shimizu S, Krafchak C, Fuse N, et al. A locus for posterior polymorphous corneal dystrophy (PPCD3) maps to chromosome 10. Am J Med Genet A 2004;130A:372-377.
• Oyakhire JO, Moroi SE. Clinical and anatomical reversal of long-term hypotony maculopathy. Am J Ophthalmol 2004;37(5):953-5.
• Wu W, Dawson DG, Sugar A, et al. Cataract surgical results and complications in a case series of patients with nanophthalmos. J Cat Refract Surg 2004;30(3):584-90.
• Moroi SE, Lark KK, Sieving PA, et al. Long anterior zonules and pigment dispersion. Am J Ophthalmol 2003;136:1176-1178.
• Eibschitz-Tsimhoni M, Johnson MW, Johnson TM, Moroi SE. Coats' syndrome as a cause of secondary open-angle glaucoma. Ophthalmic Surg Lasers 2003;34:312-314.
• McLaren NC, Moroi SE. Clinical implications of pharmacogenetics for glaucoma therapeutics. Pharmacogenomics 2003;3:197-201.
• Eibschitz-Tsimhoni M, Lichter P, Del Monte M, et al. Assessing the need for posterior sclerotomy at the time of filtering surgery in patients with Sturge-Weber syndrome. Ophthalmology 2003;110:1361-1363.
• Inoue-Matsuhisa E, Moroi SE, Takenaka H, Sogo S, Mano, T. 5-HT2 receptor-mediated phosphoinositide hydrolysis in bovine ciliary epithelium. J Ocular Pharmacol Therap 2003;19:55-62.
• Brown DJ, Kim TB, Petty EM, et al. Characterization of a stapes ankylosis family with a NOG mutation. Otol Neurotol 2003;24:210-215.
• Moroi SE, Gokhale P, Schteingart MT, et al. Clinicopathologic correlation and genetic analysis in a case of posterior polymorphous corneal dystrophy. Am J Ophthalmol 2003;135:461-470.
• Brown DJ, Kim TB, Petty EM, et al. Autosomal dominant stapes ankylosis, broad thumbs, hyperopia and skeletal anomalies caused by a heterozygous nonsense mutation in the noggin gene (NOG). Am J Hum Genet 2002;71:618-624.